Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tempus AI (TEM) Cash from Financing Activities (2023 - 2025)

Tempus AI (TEM) has disclosed Cash from Financing Activities for 3 consecutive years, with -$3.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 1916.2% to -$3.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $884.1 million, a 78.85% increase, with the full-year FY2025 number at $884.1 million, up 78.85% from a year prior.
  • Cash from Financing Activities was -$3.6 million for Q4 2025 at Tempus AI, down from $594.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $594.7 million in Q3 2025 to a low of -$8.1 million in Q3 2024.
  • A 3-year average of $161.9 million and a median of -$179000.0 in 2024 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 21365.75% in 2025; the steepest drop was 1916.2% in 2025.
  • Tempus AI's Cash from Financing Activities stood at $78.9 million in 2023, then crashed by 100.23% to -$179000.0 in 2024, then crashed by 1916.2% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for TEM's Cash from Financing Activities are -$3.6 million (Q4 2025), $594.7 million (Q3 2025), and $293.0 million (Q1 2025).